Indian panel outlines principles for review of essential drugs list
This article was originally published in Scrip
Executive Summary
An eight-member expert panel mandated to review India's national list of essential medicines (NLEM) 2011 has put forth a first draft of ''guiding principles'' for the exercise, including a specific suggestion that the annual sales figures of drugs should not be a consideration while including medicines in the list of essential drugs.